News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Nycomed Says Growth in China Helped Revenues



8/29/2011 12:57:20 PM

August 29, 2011 -- Nycomed, a privately owned Swiss biopharma, said its recent acquisition of Guangdong Techpool Biopharma and a direct sales model in China boosted the company’s revenues in Q2. Asia-Pacific, Africa and Middle East saw revenues climb by 81%, though the company did not break out China sales separately. In November 2010, Nycomed announced it would spend $210 million to purchase a 51% stake in Techpool, a biologics company. More details....

Read at ChinaBio Today


comments powered by Disqus
Nycomed
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES